Codruța Chiuzan
Impact in
- Nephrology top 5%
- Parathyroid Disorders and Treatments
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 4
- Cancer Immunotherapy and Biomarkers 3
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 5
- Co-authors
- Mathew S. Maurer (6 shared papers)Albert J. DeLuca (2 shared papers)Sabahat Bokhari (2 shared papers)Adam Castaño (2 shared papers)Anjali Saqi (4 shared papers)Catherine A. Shu (4 shared papers)Naiyer A. Rizvi (4 shared papers)Justin F. Gainor (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)PLoS ONE (3 papers)Journal of Thoracic and Cardiovascular Surgery (3 papers)Cancer Research (3 papers)ASAIO Journal (2 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Codruța Chiuzan
54 papers receiving 1.7k citations
Codruța Chiuzan's Hit Papers
Peers
Comparison fields: 5 of 104
- Nephrology 155
- Oncology 463
- Pulmonary and Respiratory Medicine 435
- Cardiology and Cardiovascular Medicine 211
- Molecular Biology 520
Countries citing papers authored by Codruța Chiuzan
This map shows the geographic impact of Codruța Chiuzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Codruța Chiuzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Codruța Chiuzan more than expected).
Fields of papers citing papers by Codruța Chiuzan
This network shows the impact of papers produced by Codruța Chiuzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Codruța Chiuzan. The network helps show where Codruța Chiuzan may publish in the future.
Co-authors
The 25 scholars most cited alongside Codruța Chiuzan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement Hit paper breakdown → | 2017 | 453 |
| 2 | Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial Hit paper breakdown → | 2020 | 438 |
| 3 | 2017 | 93 | |
| 4 | 2015 | 78 | |
| 5 | 2008 | 68 | |
| 6 | 2022 | 54 | |
| 7 | 2018 | 52 | |
| 8 | 2017 | 39 | |
| 9 | 2016 | 36 | |
| 10 | 2020 | 32 | |
| 11 | 2017 | 31 | |
| 12 | 2018 | 31 | |
| 13 | 2017 | 28 | |
| 14 | 2016 | 21 | |
| 15 | 2019 | 16 | |
| 16 | 2017 | 16 | |
| 17 | 2015 | 16 | |
| 18 | 2021 | 15 | |
| 19 | 2021 | 13 | |
| 20 | 2020 | 13 |
About Codruța Chiuzan
Codruța Chiuzan is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Biomedical Engineering and Surgery, having authored 59 papers that have together received 1.7k indexed citations. Recurring topics across this work include Mechanical Circulatory Support Devices (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Cancer Treatment and Pharmacology (4 papers), BRCA gene mutations in cancer (3 papers), Advanced Breast Cancer Therapies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Healthcare Policy and Management (2 papers). The work is most often cited by research in Nephrology (155 citations), Oncology (463 citations), Pulmonary and Respiratory Medicine (435 citations), Cardiology and Cardiovascular Medicine (211 citations) and Molecular Biology (520 citations). Codruța Chiuzan has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Mathew S. Maurer, Albert J. DeLuca, Sabahat Bokhari, Adam Castaño, Anjali Saqi, Catherine A. Shu, Naiyer A. Rizvi, Justin F. Gainor, Joshua Sonett and Mark M. Awad. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Journal of Thoracic and Cardiovascular Surgery, Cancer Research and ASAIO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.